2026 guidance assumes 2-3% volume growth in both segments
UHS reported strong Q4 2025 results with 9% revenue growth and 20% adjusted EPS growth, and provided 2026 guidance for 6-8% revenue growth and 4-13% adjusted EPS growth. Management highlighted growth initiatives, AI adoption, and addressed headwinds from exchange volumes and California staffing regulations. Q4 2025 adjusted EPS was $5.88, up 20% YoY.
Buzzberg 분석2026 guidance assumes 2-3% volume growth in both segmentsUHS reported strong Q4 2025 results with 9% revenue growth and 20% adjusted EPS growth, and provided 2026 guidance for 6-8% revenue growth and 4-13% adjusted EPS growth. Management highlighted growth initiatives, AI adoption, and addressed headwinds from exchange volumes and California staffing regulations. Q4 2025 adjusted EPS was $5.88, up 20% YoY.전체 분석 보기분석 접기
UHS reported strong Q4 2025 results with 9% revenue growth and 20% adjusted EPS growth, and provided 2026 guidance for 6-8% revenue growth and 4-13% adjusted EPS growth. Management highlighted growth initiatives, AI adoption, and addressed headwinds from exchange volumes and California staffing regulations. Q4 2025 adjusted EPS was $5.88, up 20% YoY.
2026 guidance implies 2-3% same-facility volume growth in both acute and behavioral segments.
Headwinds for 2026 include a $75M adverse impact from reduced ACA exchange volumes and a $35M impact from new California psychiatric staffing regulations.
Management expressed confidence in behavioral volume recovery after investments in staffing headcount.
Revenue$4.486B
reported
EPS$5.88
reported
Op margin11.53%
reported
Free cash flow$0.2935B
reported
이번 분기에 달라진 점
01
Guidance
2026 guidance assumes 2-3% volume growth in both segments
Guidance · revenue to $18.6B
02
Macro
Exchange volume decline to hit acute care by $75 million
Q4 2025 adjusted EPS was $5.88, up 20% YoY.
03
Regulation
California staffing rule to cost $35 million in 2026
2026 guidance implies 2-3% same-facility volume growth in both acute and behavioral segments.
04
Pricing
Behavioral pricing growth expected to moderate to 2-3%
Headwinds for 2026 include a $75M adverse impact from reduced ACA exchange volumes and a $35M impact from new California psychiatric staffing regulations.
AI, 자본지출 및 수요 분석
AI
플랫폼 및 수익화
Management is deploying AI across operations and administration, focusing on post-discharge care, patient safety, revenue cycle, and behavioral intake. They highlighted a partnership with Hippocratic AI and expect these efforts to drive efficiency and quality improvements, though they are early in realizing financial impact.
수요
수주 및 전환
Las Vegas acute care volumes soft but expected to improve. Management expressed confidence in the 2026 outlook, citing strong cash generation, disciplined expense management, and specific catalysts like improvement in Las Vegas and behavioral volume growth, while acknowledging known headwinds.
자본지출
투자 및 생산능력
Capital expenditures are expected to be $950 million to $1.1 billion in 2026, directed toward completing several large inpatient projects including a new hospital in Florida and expansions in California and Nevada, while also growing outpatient behavioral locations.
톤 · Confident
Management expressed confidence in the 2026 outlook, citing strong cash generation, disciplined expense management, and specific catalysts like improvement in Las Vegas and behavioral volume growth, while acknowledging known headwinds.
공급망 알파
A1
UHS assumes a 25-30% decline in ACA exchange volumes in 2026, with 10-20% shifting to other coverage and the majority becoming self-pay/uninsured, a $75M pre-tax headwind.
“We assume an adverse pre-tax earnings impact of approximately $75 million related to reductions in the health insurance exchanges. We assume that exchange volumes will decline by 25 to 30%”
New California inpatient psychiatric hospital staffing regulations will be a $35M headwind in 2026, with ~$30M in ongoing annual costs, as UHS adjusts its licensed nursing mix.
“We expect a negative pre-tax earnings impact of approximately $35 million in our behavioral segment associated with the recently enacted California inpatient psychiatric hospital staffing regulations”
UHS is deploying agentic AI for post-discharge care and revenue cycle management, focusing on headcount reduction and operational efficiency.
“we're using an AI agent to make those calls in many cases. And so in both cases, I think we're driving efficiencies. It allows us to reduce headcount.”
UHS's acute care same-facility length of stay is down 2%, but the biggest obstacle to further improvement is a shortage of sub-acute capacity (SNFs, LTACs).
“I think probably the single biggest obstacle we've faced in not reducing length of stay further is the supply of sub-acute capacity”